/home/corante/public_html/brainwaves/ The field of neurotechnology, the focus of this blog, encompasses advances in brain science (neurons), information technology (bits) and bioengineering (genes). Up for discussion and analysis: the political, economic, ethical, and social forces that will shape the future of what will be one of the most important and fascinating stories of the coming decades. en-us zack@neuroinsights.com 2006-09-27T13:47:38-05:00 hourly 1 2000-01-01T12:00+00:00 http://brainwaves.corante.com/archives/2006/09/27/brain_fitness_software_market_sprouts_wings.php Spurred by the discovery of neuroplasticity, the aging baby boomer population and demand for safe interventions for childhood ADHD, software companies, large and small, are venturing into the realm of therapy and cognitive fitness. Venture investors are drawn by the... 66248@/home/corante/public_html/brainwaves/ VC for Neurotech 2006-09-27T13:47:38-05:00 http://brainwaves.corante.com/archives/2006/04/12/neurotech_industry_investing_conference_may_18th_register_today.php Join investors, executives and leading researchers from across neurotech to discuss the latest developments in drugs, devices and diagnostics for the brain and nervous system on May 18th in San Francisco. The Neurotech Industry Investing and Business Conference is... 55413@/home/corante/public_html/brainwaves/ VC for Neurotech 2006-04-12T14:55:04-05:00 http://brainwaves.corante.com/archives/2005/07/18/braincells_taps_leading_neurotech_venture_capital.php By Casey Lynch Neuropharmaceutical drug discovery company BrainCells Inc of San Diego announced that it has closed a $17.7 million Series A financing from leading neurotech venture funds including Technology Partners, Oxford Bioscience Partners and NeuroVentures Capital. Recent research from... 4473@/home/corante/public_html/brainwaves/ VC for Neurotech 2005-07-18T17:26:57-05:00